Sources | Names Used |
---|---|
GDSC1000, FIMM | Bexarotene |
CTRPv2 | bexarotene |
PharmacoGx | Bexarotene |
Database | Identifier |
---|---|
Smiles: | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
Inchikey: | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
Pubchem: | 82146 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PELI1 | GDSC1000 | pan-cancer | AAC | -0.19 | 7e-07 |
mRNA | MRC2 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-07 |
mRNA | PGLS | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
mRNA | CD300LF | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | FOSL2 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-07 |
mRNA | RGS9 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
mRNA | AC006026.1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | CD160 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | MS4A3 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | MFNG | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-06 |